News | January 11, 2007

Newly Cleared Mapping Catheter Deflects in Two Directions

Jan. 12, 2007 — The FDA has cleared St. Jude Medical’s Reflexion Spiral Variable Radius Mapping Catheter and a faster, smaller EnSite System workstation computer.

The products are being debuted today and Saturday at the Boston Atrial Fibrillation Symposium a meeting of leading electrophysiologists in the field of arrhythmia and atrial fibrillation (AF) management from around the world.

The Reflexion Spiral Variable Radius features a circular loop at the tip that expands from 15 mm to 25 mm to fit a variety of patient anatomies. It is the only variable radius circular mapping catheter available with bi-directional deflection, which provides enhanced versatility for complex left atrial procedures. It also features the proprietary ComfortGrip handle to give physicians improved comfort and control during electrophysiology (EP) procedures.

"The ability of the catheter to deflect in both directions is a very useful benefit, and the handle proved extremely comfortable and easy to use," said Andrea Natale, M.D., Cleveland Clinic, one of the first physicians to use the product.

The EnSite System provides highly detailed, 3-D cardiac models that help physicians diagnose and treat many arrhythmias, including AF. The system is now available with a new computer, featuring twin dual-core processors for enhanced processing speed. Many of the most complex processing and image rendering times have been reduced by up to 80 percent, allowing clinicians to obtain, display and analyze information faster.


Related Content

News

Sept. 8, 2026 — Abbot has announced that it has received U.S. Food and Drug Administration (FDA) approval for the ...

Home September 08, 2026
Home
News

Aug. 31, 2026 — At the European Society of Cardiology Congress in Munich, Abbott announced new late-breaking 12-month ...

Home September 02, 2026
Home
News

July 8, 2026 — Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) approved the Dual Energy ...

Home July 08, 2026
Home
News

May 21, 2026 — Adagio Medical Holdings, a provider of catheter ablation technologies for treating cardiac arrhythmias ...

Home May 22, 2026
Home
News

April 26, 2026 — New results from the multicenter catheter ablation versus anti-arrhythmic drugs for Ventricular ...

Home April 29, 2026
Home
News

April 24, 2026 — Johnson & Johnson recently announced the initiation of the PERSIGMA randomized controlled trial (RCT) ...

Home April 27, 2026
Home
News

April 26, 2026 – New results from the pivotal multicenter trial FULCRUM-VT show that ultra-low temperature ablation ...

Home April 27, 2026
Home
News

April 13, 2026 — Johnson & Johnson has announced favorable 12-month interim effectiveness and safety results from ...

Home April 13, 2026
Home
News

In a milestone for Broward Health in Ft. Lauderdale, Fla., Jose L. Baez-Escudero, M.D., chief of cardiology and ...

Home March 24, 2026
Home
News

Feb. 6, 2026 — Abbott has announced new clinical data from two late-breaking presentations at AF Symposium in Boston ...

Home February 06, 2026
Home
Subscribe Now